Showing results (1451-1460 of 1,713) with videos related to
Sort By:
Pageof 172
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancerDenis C Talbot, Joachim von Pawel, Emma Cattell, et al.Scientific Reports|September 9, 2017
Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophagesCaterina Di Pietro, Ping-Xia Zhang, Timothy K O'Rourke, et al.British Journal of Cancer|December 1, 1996
Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groupsH L McLeod, L S Murray, J Wanders, et al.Journal of Leukocyte Biology|October 4, 2024
CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and cystic fibrosis miceHasan H Öz, Cassia L Braga, Ravindra Gudneppanavar, et al.Nature Communications|April 16, 2015
Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signallingGina L Zoratti, Lauren M Tanabe, Fausto A Varela, et al.The Journal of Urology|February 11, 2016
Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in SwineKatie S Murray, Ashley G Winter, Renato Beluco Corradi, et al.Nature Communications|November 30, 2017
Counter-intuitive influence of Himalayan river morphodynamics on Indus Civilisation urban settlementsAjit Singh, Kristina J Thomsen, Rajiv Sinha, et al.Molecular Biology and Evolution|June 1, 2022
Genetic Variation in Reproductive Investment Across an Ephemerality Gradient in Daphnia pulexKaren B Barnard-Kubow, Dörthe Becker, Connor S Murray, et al.Lung Cancer (Amsterdam, Netherlands)|March 29, 2006
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patientsS Murray, E Timotheadou, H Linardou, et al.Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.Pageof 172